Laparoscopic Roux-en-Y gastric bypass versus laparoscopic mini gastric bypass in the treatment of obesity: study protocol for a randomized controlled trial

Abstract

BackgroundLaparoscopic Roux-en-Y gastric bypass (LRYGB) is considered the gold standard in bariatric surgery, achieving durable long-term weight loss with improvement of obesity-related comorbidities. Lately, the laparoscopic mini gastric bypass (LMGB) has gained worldwide popularity with similar results to LRYGB in terms of weight loss and comorbidity resolution. However, there is a lack of randomized controlled trials (RCT) comparing LMGB and LRYGB. This article describes the design and protocol of a randomized controlled trial comparing the outcomes of these two bariatric procedures.Methods/DesignThe trial is designed as a single center, randomized, patient and observer blinded trial. The relevant ethics committee has approved the trial protocol. To demonstrate that LMGB is not inferior to LRYGB in terms of excess weight loss (EWL) the study is conducted as a non-inferiority trial with the sample-size calculations performed accordingly. EWL 12 months after surgery is the primary endpoint, whereas 3-year EWL, morbidity, mortality, remission of obesity related comorbidities, quality of life (QOL) and hormonal and lipid profile changes are secondary endpoints. Eighty patients, 18 years or older and with a body mass index (BMI) between 35 and 50 kg/m2 who meet the Swiss guidelines for the surgical treatment of morbid obesity will be randomized. The endpoints and baseline measurements will be assessed pre-surgery, peri-surgery and post-surgery (fixed follow up measurements are at discharge and at the time points 6 weeks and 12 and 36 months postoperatively).DiscussionWith its 3-year follow up time, this RCT will provide important data on the impact of LMGB and LRYGB on EWL, remission of comorbidities, QOL and hormonal and lipid profile changes.Trial registrationClinicalTrials.gov, NCT02601092. Registered on 28 September 2015.Electronic supplementary materialThe online version of this article (doi:10.1186/s13063-017-1957-9) contains supplementary material, which is available to authorized users.

Weighing in on heart failure: the potential impact of bariatric surgery

“…As a result of the accumulation of adipose tissue and increased body mass, patients with obesity have a higher blood volume that requires higher cardiac output, which is achieved by increasing stroke volume, all of which leads to higher cardiac workload [19]. These hemodynamic changes lead to increased left ventricular size, wall stress, and subsequent eccentric left ventricular hypertrophy, subsequently predisposing to left ventricular failure [2].…”

Aktuelle Aspekte der Verfahrenswahl bei Adipositas-Chirurgie

“…Zwar gibt es zwei vergleichende prospektiv randomisierte Studien [47,48], jedoch zeigen diese erhebliche methodische Schwächen. Aktuell rekrutieren mehrere RCT, deren Ergebnisse bislang noch nicht vorliegen [49].…”

The treatment of the metabolic syndrome with stapleless one-anastomotic gastric bypass: a randomized clinical trial compared to stapler method

“…Если сравнивать полученные нами результаты по снижению массы тела, то они сопоставимы с данными, полученными в других исследованиях, изучавших результаты применения гастрошунтирования [12,13].…”